<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Basalely AM</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>1353-1360</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10228559</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(10)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine the association of dysnatremia in the first postnatal week and risk of acute kidney injury (AKI) and mortality.&lt;h4>Study design&lt;/h4>A secondary analysis of 1979 neonates in the AWAKEN cohort evaluated the association of dysnatremia with (1) AKI in the first postnatal week and (2) mortality, utilizing time-varying Cox proportional hazard models.&lt;h4>Result&lt;/h4>Dysnatremia developed in 50.2% of the cohort and was not associated with AKI. Mortality was associated with hyponatremia (HR 2.15, 95% CI 1.07-4.31), hypernatremia (HR 4.23, 95% CI 2.07-8.65), and combined hypo/hypernatremia (HR 6.39, 95% CI 2.01-14.01). In stratified models by AKI-status, hypernatremia and hypo/hypernatremia increased risk of mortality in neonates without AKI.&lt;h4>Conclusion&lt;/h4>Dysnatrem</pubmed_abstract><journal>Journal of perinatology : official journal of the California Perinatal Association</journal><pubmed_title>Association of early dysnatremia with mortality in the neonatal intensive care unit: results from the AWAKEN study.</pubmed_title><pmcid>PMC10228559</pmcid><funding_grant_id>T32 DK007110</funding_grant_id><funding_grant_id>UL1 TR003096</funding_grant_id><funding_grant_id>UL1 TR002556</funding_grant_id><funding_grant_id>U54 TR001356</funding_grant_id><funding_grant_id>UL1 TR001417</funding_grant_id><funding_grant_id>UL1 TR001449</funding_grant_id><pubmed_authors>Sridhar S</pubmed_authors><pubmed_authors>Goldstein S</pubmed_authors><pubmed_authors>Charlton J</pubmed_authors><pubmed_authors>Colaizy T</pubmed_authors><pubmed_authors>Gien J</pubmed_authors><pubmed_authors>Brophy P</pubmed_authors><pubmed_authors>Ray P</pubmed_authors><pubmed_authors>Mian A</pubmed_authors><pubmed_authors>Singh AJ</pubmed_authors><pubmed_authors>Jetton J</pubmed_authors><pubmed_authors>Ingraham S</pubmed_authors><pubmed_authors>Bhutada A</pubmed_authors><pubmed_authors>Griffin R</pubmed_authors><pubmed_authors>Juul S</pubmed_authors><pubmed_authors>Hanna M</pubmed_authors><pubmed_authors>Dupont T</pubmed_authors><pubmed_authors>Sarker S</pubmed_authors><pubmed_authors>AWAKEN Study Group</pubmed_authors><pubmed_authors>Ambalavanan N</pubmed_authors><pubmed_authors>Nathan A</pubmed_authors><pubmed_authors>Sethi S</pubmed_authors><pubmed_authors>Fletcher J</pubmed_authors><pubmed_authors>Duara S</pubmed_authors><pubmed_authors>Charlton JR</pubmed_authors><pubmed_authors>Gist KM</pubmed_authors><pubmed_authors>Nada A</pubmed_authors><pubmed_authors>Rademacher E</pubmed_authors><pubmed_authors>Harer M</pubmed_authors><pubmed_authors>Kupferman J</pubmed_authors><pubmed_authors>Selewski D</pubmed_authors><pubmed_authors>Hu C</pubmed_authors><pubmed_authors>Defreitas M</pubmed_authors><pubmed_authors>Revenis M</pubmed_authors><pubmed_authors>Wazir S</pubmed_authors><pubmed_authors>Mhanna M</pubmed_authors><pubmed_authors>Guillet R</pubmed_authors><pubmed_authors>Askenazi DJ</pubmed_authors><pubmed_authors>Basalely AM</pubmed_authors><pubmed_authors>Wintermark P</pubmed_authors><pubmed_authors>El Samra A</pubmed_authors><pubmed_authors>Mammen C</pubmed_authors><pubmed_authors>Selewski DT</pubmed_authors><pubmed_authors>Sethna F</pubmed_authors><pubmed_authors>Woroniecki R</pubmed_authors><pubmed_authors>Ohls R</pubmed_authors><pubmed_authors>Perrazo S</pubmed_authors><pubmed_authors>Reidy KJ</pubmed_authors><pubmed_authors>Ariken A</pubmed_authors><pubmed_authors>Rhee C</pubmed_authors><pubmed_authors>Chishti A</pubmed_authors><pubmed_authors>Wong C</pubmed_authors><pubmed_authors>D'Angio CT</pubmed_authors><pubmed_authors>Synnes A</pubmed_authors><pubmed_authors>Schwartz G</pubmed_authors><pubmed_authors>Zappitelli M</pubmed_authors><pubmed_authors>Uy N</pubmed_authors><pubmed_authors>Dubey S</pubmed_authors><pubmed_authors>Kaskel F</pubmed_authors><pubmed_authors>Kent A</pubmed_authors><pubmed_authors>Raina R</pubmed_authors><pubmed_authors>Greenberg J</pubmed_authors><pubmed_authors>Fine R</pubmed_authors><pubmed_authors>Milner L</pubmed_authors><pubmed_authors>Fuloria M</pubmed_authors><pubmed_authors>Smith A</pubmed_authors><pubmed_authors>Soranno D</pubmed_authors><pubmed_authors>Askenazi D</pubmed_authors><pubmed_authors>Gist K</pubmed_authors><pubmed_authors>Hingorani S</pubmed_authors><pubmed_authors>Klein J</pubmed_authors><pubmed_authors>Kaskel FJ</pubmed_authors><pubmed_authors>Kumar D</pubmed_authors><pubmed_authors>Nicoletta J</pubmed_authors><pubmed_authors>Yasin S</pubmed_authors><pubmed_authors>Bonachea E</pubmed_authors><pubmed_authors>Reidy K</pubmed_authors><pubmed_authors>Joseph C</pubmed_authors><pubmed_authors>Abitbol C</pubmed_authors><pubmed_authors>Rastogi S</pubmed_authors><pubmed_authors>Swanson J</pubmed_authors><pubmed_authors>Staples A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of early dysnatremia with mortality in the neonatal intensive care unit: results from the AWAKEN study.</name><description>&lt;h4>Objective&lt;/h4>To determine the association of dysnatremia in the first postnatal week and risk of acute kidney injury (AKI) and mortality.&lt;h4>Study design&lt;/h4>A secondary analysis of 1979 neonates in the AWAKEN cohort evaluated the association of dysnatremia with (1) AKI in the first postnatal week and (2) mortality, utilizing time-varying Cox proportional hazard models.&lt;h4>Result&lt;/h4>Dysnatremia developed in 50.2% of the cohort and was not associated with AKI. Mortality was associated with hyponatremia (HR 2.15, 95% CI 1.07-4.31), hypernatremia (HR 4.23, 95% CI 2.07-8.65), and combined hypo/hypernatremia (HR 6.39, 95% CI 2.01-14.01). In stratified models by AKI-status, hypernatremia and hypo/hypernatremia increased risk of mortality in neonates without AKI.&lt;h4>Conclusion&lt;/h4>Dysnatrem</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T03:00:46.464Z</modification><creation>2025-04-04T03:00:46.464Z</creation></dates><accession>S-EPMC10228559</accession><cross_references><pubmed>34775486</pubmed><doi>10.1038/s41372-021-01260-x</doi></cross_references></HashMap>